Aeluma Q4 Revenue Falls on R&D Contracts, Loss Widens
ALMU sits 23% above its 52-week low of $10.24 on elevated volume (2.5× avg).
Summary
Aeluma reported Q4 revenue of $600,000, slightly above the $575,000 consensus, but the loss per share of $0.22 and widening net loss reflect heavy investments in hiring and manufacturing readiness. The company signed six new contracts totaling $5.3 million and expanded partnerships with Tower Semiconductor and Sumitomo Chemical Advanced Technologies. Management is negotiating NRE agreements with AI datacom customers and expects CHIPS R&D funding to accelerate commercialization. The stock trades at $12.64, well below the median analyst target of $30, but the near-term focus on spending over profitability may pressure shares. Aeluma filed an 8-K regarding operations and financial condition.
At the time of this announcement, ALMU was trading at $12.64 on NASDAQ in the Technology sector, with a market capitalization of approximately $258.7M. The 52-week trading range was $10.24 to $31.79. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.